Novartis Pharma AG (Switzerland)
David Lossignol is currently Head of Trademarks, Domain Names and Copyrights at Novartis Pharma AG in Basel, Switzerland, leading a team of experienced trademark professionals handling all trademark, domain name and copyright matters for Novartis Pharma worldwide. He joined Novartis Pharma AG in Basel in January 2019 and was previously Global Head of Trademarks at Sandoz International GmbH in Holzkirchen, Germany from November 2015 until December 2018. Mr. Lossignol was previously Senior Trademark Attorney at Novartis Pharma AG in Basel, Switzerland, where he was responsible for worldwide trademark, design and domain name portfolios, and various related pan-European litigation matters.
Before joining Novartis Pharma AG in January 2010 as Trademark Attorney, Mr. Lossignol was, since 2006, Head of Trademarks and Domain Names at Virbac S.A., a company in the animal health sector located in Carros, close to Nice, France. There, he was in charge of the worldwide trademark, design and domain name strategy for the Group. Mr. Lossignol started at Virbac as an intern in 1999 before joining as Trademark and Domain Name Counsel in 2001. He also acted as Legal Counsel for the company in 2002, mainly in charge of drafting and negotiating agreements.
Mr. Lossignol obtained law degrees at Nice Sophia-Antipolis University in France, where he has also lectured on IP law, and diplomas from Oxford Brookes University in the UK and from the CEIPI in Strasbourg, France.
In his role as INTA President, Mr. Lossignol is Chair of the Board of Directors and Executive Committee. He is also a member of the Association’s Brands and Innovation Committee.